BioNanoNet Forschungsgesellschaft mbH (BNN) is a scientific network that specializes in the Key Enabling Technologies nanotechnology and biotechnology located in Austria, with the emphasis on (1) nanotoxicology, (2) sensortechnologies, as well as (3) health, (nano-)safety and (nano-) medicine, and additionally supports projects in coordination, management, dissemination and communication.
BioNanoNet Forschungsgesellschaft mbH (BNN) is a European key player in the field of nano-safety, specialised in developing nano-safety-by-design strategies together with researchers and industry, and coordinator of international nano-safety and nano-innovation activities (e.g., Industrial Innovation Liaisons, Closer-To-The-Market, etc.).
BioNanoNet Forschungsgesellschaft mbH (BNN) has the clear aim of driving innovative interdisciplinary research by supporting the cooperation by bringing together scientific experts and industry to gain critical mass for thematic areas, to initiate, set up and manage national as well as international research projects and to add value by providing nano-safety strategies tailored to the needs of organisations. Therefore, BioNanoNet Forschungsgesellschaft mbH (BNN) continuously interacts with national and international stakeholders, as well as policy makers and regulatory and legislative authorities (e.g., in the context of NANoREG, EURO-NanoTox, standardisation committees, etc.).
Furthermore, BioNanoNet Forschungsgesellschaft mbH (BNN) has on-going cooperation with nearly all European countries, is actively shaping Europe’s research and innovation strategy by contributing to the development of strategic agendas of leading European Technology Platforms.
BioNanoNet Forschungsgesellschaft mbH (BNN) coordinates the Austrian NanoSafety-Research-community and therefore has access to key technologies for nano-safety assessment along the value chain (e.g., nano-safety-by-design strategies). It provides communication and dissemination services; its newsletters reaches “nano-professionals” worldwide. Standardisation and regulatory aspects of nanotechnology (e.g. safety data sheets, exposure scenarios, REACH context, etc.) is key topics in the research of BioNanoNet Forschungsgesellschaft mbH (BNN).
Within Smart4Fabry, BioNanoNet Forschungsgesellschaft mbH (BNN) will responsible for defining a comprehensive safety and standardisation strategy. Each process within the project will be screened towards nanosafety and standardization of processes together with the technical developers. Moreover, BNN will in terms of regulatory aspects of nanotechnology bring in its know-how gained within previous projects (e.g., NANOFORCE), will connect the project with NANoREG-project, and will be responsible for cooperation with working groups of NanoSafetyCluster.